Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

Similar articles for PubMed (Select 20159940)

1.

Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs.

Howell SB, Safaei R, Larson CA, Sailor MJ.

Mol Pharmacol. 2010 Jun;77(6):887-94. doi: 10.1124/mol.109.063172. Epub 2010 Feb 16. Review.

2.
3.

Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.

Samimi G, Howell SB.

Cancer Chemother Pharmacol. 2006 Jun;57(6):781-8. Epub 2005 Sep 17.

PMID:
16170571
4.

Contributions of rat Ctr1 to the uptake and toxicity of copper and platinum anticancer drugs in dorsal root ganglion neurons.

Liu JJ, Kim Y, Yan F, Ding Q, Ip V, Jong NN, Mercer JF, McKeage MJ.

Biochem Pharmacol. 2013 Jan 15;85(2):207-15. doi: 10.1016/j.bcp.2012.10.023. Epub 2012 Nov 1.

PMID:
23123662
5.

Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin.

Blair BG, Larson CA, Safaei R, Howell SB.

Clin Cancer Res. 2009 Jul 1;15(13):4312-21. doi: 10.1158/1078-0432.CCR-09-0311. Epub 2009 Jun 9.

6.

Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B.

Samimi G, Katano K, Holzer AK, Safaei R, Howell SB.

Mol Pharmacol. 2004 Jul;66(1):25-32.

7.

Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells.

Song IS, Savaraj N, Siddik ZH, Liu P, Wei Y, Wu CJ, Kuo MT.

Mol Cancer Ther. 2004 Dec;3(12):1543-9. Erratum in: Mol Cancer Ther. 2005 May;4(5):864.

8.

Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs.

Safaei R, Howell SB.

Crit Rev Oncol Hematol. 2005 Jan;53(1):13-23. Review.

PMID:
15607932
9.

Effects of the loss of Atox1 on the cellular pharmacology of cisplatin.

Safaei R, Maktabi MH, Blair BG, Larson CA, Howell SB.

J Inorg Biochem. 2009 Mar;103(3):333-41. doi: 10.1016/j.jinorgbio.2008.11.012. Epub 2008 Nov 30.

10.

Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells.

Samimi G, Safaei R, Katano K, Holzer AK, Rochdi M, Tomioka M, Goodman M, Howell SB.

Clin Cancer Res. 2004 Jul 15;10(14):4661-9.

11.

Sec61β controls sensitivity to platinum-containing chemotherapeutic agents through modulation of the copper-transporting ATPase ATP7A.

Abada PB, Larson CA, Manorek G, Adams P, Howell SB.

Mol Pharmacol. 2012 Sep;82(3):510-20. doi: 10.1124/mol.112.079822. Epub 2012 Jun 18.

12.

The roles of copper transporters in cisplatin resistance.

Kuo MT, Chen HH, Song IS, Savaraj N, Ishikawa T.

Cancer Metastasis Rev. 2007 Mar;26(1):71-83. Review.

PMID:
17318448
13.

Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells.

Blair BG, Larson CA, Adams PL, Abada PB, Safaei R, Howell SB.

Mol Pharmacol. 2010 Jun;77(6):912-21. doi: 10.1124/mol.109.062836. Epub 2010 Mar 1.

14.

The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae.

Lin X, Okuda T, Holzer A, Howell SB.

Mol Pharmacol. 2002 Nov;62(5):1154-9. Erratum in: Mol Pharmacol. 2003 Apr;63(4):957.

15.

Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.

Kitada N, Takara K, Minegaki T, Itoh C, Tsujimoto M, Sakaeda T, Yokoyama T.

Cancer Chemother Pharmacol. 2008 Sep;62(4):577-84. Epub 2007 Nov 21.

PMID:
18030470
16.

The role of the mammalian copper transporter 1 in the cellular accumulation of platinum-based drugs.

Larson CA, Blair BG, Safaei R, Howell SB.

Mol Pharmacol. 2009 Feb;75(2):324-30. doi: 10.1124/mol.108.052381. Epub 2008 Nov 7.

17.
18.

The role of the methionines and histidines in the transmembrane domain of mammalian copper transporter 1 in the cellular accumulation of cisplatin.

Larson CA, Adams PL, Blair BG, Safaei R, Howell SB.

Mol Pharmacol. 2010 Sep;78(3):333-9. doi: 10.1124/mol.110.064766. Epub 2010 Jun 2.

19.

Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells.

Kalayda GV, Wagner CH, Jaehde U.

J Inorg Biochem. 2012 Nov;116:1-10. doi: 10.1016/j.jinorgbio.2012.07.010. Epub 2012 Jul 26.

PMID:
23010323
20.

Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.

Shang X, Lin X, Manorek G, Howell SB.

Mol Pharmacol. 2013 Jan;83(1):85-94. doi: 10.1124/mol.112.079798. Epub 2012 Oct 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk